{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$8.28 vs. cons $8.16",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$5.53B vs. cons $5.49B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted segment operating margin",
      "prediction": "BEAT",
      "answer": "pred ~27.8% vs. cons 27.4%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2027 organic sales growth",
      "prediction": "LOWER",
      "answer": "guide ~4.5% vs. cons 5.3% (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2027 adjusted segment operating margin",
      "prediction": "UNCHANGED",
      "answer": "guide ~27.7% vs. cons 27.7% (FY2027)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY2027 adjusted EPS",
      "prediction": "LOWER",
      "answer": "guide ~$33.90 vs. cons $34.45 (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2027 free-cash-flow conversion",
      "prediction": "UNCHANGED",
      "answer": "guide ~100% vs. cons 100% (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest Q4 EPS and margin beat is likely outweighed by FY2027 organic-growth and EPS guidance of ~4.5% and ~$33.90 versus consensus 5.3% and $34.45; the implied out-period reset should drive estimate cuts after the report.",
  "day5_confidence": "MEDIUM"
}